| 期 |
栏目 |
标题 |
文件 |
| 卷 81, 编号 8 (2009) |
Editorial |
Clinical implications of urine matrix metalloproteinases assay in patients with chronic glomerulonephritis |
|
| 卷 82, 编号 6 (2010) |
Editorial |
Mechanisms of phosphorus and calcium homeostatic disorders in the development of cardiovascular events in patients with chronic renal diseases. The role of fibroblast growth factor 23 and Klotho |
|
| 卷 83, 编号 6 (2011) |
Editorial |
Estimation of podocyte dysfunction by nephrinuria severity in proteinuric forms of chronic glomerulonephritis |
|
| 卷 84, 编号 6 (2012) |
Editorial |
NEPHROTIC CRISIS — AN URGENT CONDITION IN PATIENTS WITH NEPHROTIC SYNDROME |
|
| 卷 90, 编号 6 (2018) |
Editorial |
The role of podocytes dysfunction in chronic glomerulonephritis progression |
(Rus)
|
| 卷 90, 编号 6 (2018) |
Editorial |
Nephrological aspects of surgical weight correction in morbid obesity |
(Rus)
|
| 卷 90, 编号 6 (2018) |
Editorial |
Genetic determinants of the development and course of membranous nephropathy |
(Rus)
|
| 卷 90, 编号 9 (2018) |
Editorial |
Risk factors for diastolic left ventricular myocardial dysfunction in patients with chronic kidney disease |
(Rus)
|
| 卷 82, 编号 1 (2010) |
Editorial |
Significance of the markers of endothelial dysfunction and hemorheological disorders for assessing the activity and prognosis of chronic glomerulonephritis |
|
| 卷 92, 编号 6 (2020) |
Original articles |
The balance of proinflammatory cytokines and Treg cells in chronic glomerulonephritis |
(Rus)
|
| 卷 92, 编号 6 (2020) |
Original articles |
Changes in metabolic parameters and glomerular filtration rate in patients with morbid obesity after bariatric surgery |
(Rus)
|
| 卷 92, 编号 6 (2020) |
Original articles |
Modern view on treatment of membranous nephropathy |
(Rus)
|
| 卷 92, 编号 7 (2020) |
Consensuns |
Monoclonal gammopathy of renal significance: consensus of hematologists and nephrologists of Russia on the establishment of nosology, diagnostic approach and rationale for clone specific treatment |
(Rus)
|
| 卷 91, 编号 6 (2019) |
Articles |
Modern approaches to conservative therapy of polycystic kidney disease |
(Rus)
|
| 卷 95, 编号 9 (2023) |
Reviews |
The role of mineralocorticoid receptors hyperactivation in the development of cardiorenal complications in patients with diabetes mellitus, perspective of the selective nonsteroidal mineralocorticoid receptors antagonist’s treatment: A review |
(Rus)
|
| 卷 93, 编号 6 (2021) |
Editorial |
Kidney injury associated with antitumor therapy: focus on the adverse events of modern immuno-oncological drugs |
(Rus)
|
| 卷 93, 编号 10 (2021) |
History of medicine |
The Rehberg–Tareev test in assessing the glomerular filtration rate |
(Rus)
|
| 卷 94, 编号 6 (2022) |
Editorial |
Lupus nephritis in the XXI century |
(Rus)
|
| 卷 94, 编号 6 (2022) |
Reviews |
Modern view on the complement system role in membranous nephropathy |
(Rus)
|
| 卷 94, 编号 6 (2022) |
History of medicine |
Kidney damage caused by lead exposure: historical aspects |
(Rus)
|
| 卷 95, 编号 6 (2023) |
Editorial |
State-of-the-art paradigm of corticosteroid therapy for immune-mediated inflammatory kidney diseases |
(Rus)
|
| 卷 95, 编号 6 (2023) |
Original articles |
Clinical significance of the determination of antibodies to thrombospondin type 1 containing domain 7A (THSD7A) in membranous nephropathy |
(Rus)
|
| 卷 95, 编号 6 (2023) |
Reviews |
Frailty and chronic kidney disease – the real problem of modern nephrology: A review |
(Rus)
|
| 卷 96, 编号 6 (2024) |
Original articles |
Idiopathic membranous nephropathy with focal segmental sclerosis |
(Rus)
|
